Cochlear Ltd is a public company quoted on the Australian Stock Exchange. It manufactures Nucleus Cochlear implants, which are medical devices that help restore hearing in severely and profoundly deaf people when conventional hearing aids are no longer effective. It is the world leader in this device which is exemplified by its 65% worldwide market share. Cochlear sells its products in more than 50 countries and has in excess of 52,000 people using its products to hear and communicate.
The firm was founded in Australia in 1981. Since then it has maintained its position as an international leader in the design, manufacture and sale of cochlear implant systems. The corporate office, manufacturing facilities, principal research and development activities and its Asia Pacific regional office are located in Sydney, Australia. Cochlear also maintains offices in Basel, Denver, Hanover, Hong Kong, London, and Tokyo and has an extensive network of distributors worldwide.


My Sourcing

Cochlear (HK) Limited

Company Information

Contact